HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oleamidopropyl dimethylamine.

Abstract
The cationic emulsifier oleamidopropyl dimethylamine has been responsible for many cases of cosmetic sensitisation in The Netherlands. Of 119 patients with proven cosmetic-related allergic contact dermatitis, 13 (11%) were allergic to oleamidopropyl dimethylamine. The clinical data of 12 patients, all sensitised by one particular baby body lotion containing 0.3% of the emulsifier, are presented. The cross-reaction pattern of oleamidopropyl dimethylamine was investigated by patch testing 13 patients allergic to the emulsifier with a series of related amideamine type emulsifiers. Most cross-reactions were observed to ricinoleamidopropyl dimethylamine lactate and tallowamidopropyl dimethylamine (11 patients, 85%). 9 patients (of 12 tested: 75%) reacted to lauramidopropyl dimethylamine and 6 (46%) to myristamidopropyl dimethylamine. It is concluded that the presence of oleamidopropyl dimethylamine in a concentration of 0.3% in stay-on cosmetics, especially when applied to damaged skin and/or the periorbital area, bears a definite risk of the induction and elicitation of contact allergic reactions.
AuthorsA C de Groot
JournalDermatosen in Beruf und Umwelt. Occupation and environment (Derm Beruf Umwelt) 1989 May-Jun Vol. 37 Issue 3 Pg. 101-5 ISSN: 0343-2432 [Print] Germany
PMID2743873 (Publication Type: Journal Article)
Chemical References
  • Cosmetics
  • Dermatologic Agents
  • Emollients
  • Excipients
  • Propylamines
  • N-(3-(dimethylamino)propyl)oleamide
Topics
  • Cosmetics (adverse effects)
  • Dermatitis, Contact (etiology)
  • Dermatologic Agents (adverse effects)
  • Dose-Response Relationship, Drug
  • Emollients (adverse effects)
  • Excipients (adverse effects)
  • Humans
  • Netherlands
  • Patch Tests
  • Propylamines (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: